Skip to main content
Clinical Trials/JPRN-UMIN000031741
JPRN-UMIN000031741
Completed
未知

Feasibility study of opioid-induced nausea and vomiting - Feasibility study of opioid-induced nausea and vomiting

Teikyo University0 sites15 target enrollmentMarch 15, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Opioid-induced nausea and vomiting (OINV)
Sponsor
Teikyo University
Enrollment
15
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 15, 2018
End Date
May 15, 2019
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Brain metastasis with edema or meningeal carcinomatosis 2\)Peritoneal dissemination, intestinal obstruction or intestinal stenosis with intestinal dilation 3\) Constipation \>\= Grade 3 4\) History of diabetes requiring medication 5\) Administration of antineoplastic agents with high or moderate emetic risk within 21 days 6\) Administration of antineoplastic agents with low emetic risk within 7 days 7\) Abdominal surgery within 21 days 8\) Infection requiring systemic treatment 9\) Active peptic ulcer 10\) History of HBV infection 11\) Delirium within 1 year 12\) History of steroid psychosis 13\) Allergy to dexamethasone 14\) Other conditions inappropriate for participating in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials